Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- DOUGLAS A. S. The action of heparin in the prevention of prothrombin conversion. J Clin Invest. 1956 May;35(5):533–536. doi: 10.1172/JCI103306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FERGUSON J. H., JOHNSTON C. L., Jr, HOWELL D. A. Anti-AcG: specific circulating inhibitor of the labile clotting factor. Proc Soc Exp Biol Med. 1957 Jul;95(3):567–570. doi: 10.3181/00379727-95-23293. [DOI] [PubMed] [Google Scholar]
- HORDER M. H. Isolierter Factor V-Mangel bedingt durch einen spezifischen Hemmkörper. Acta Haematol. 1955 Apr;13(4):235–241. doi: 10.1159/000204943. [DOI] [PubMed] [Google Scholar]
- ULUTIN O. N., SESTAKOF D. Hiperkoagulabilite Uzerinde bir çalişma. Turk Tip Cemiy Mecm. 1957 Dec;23(12):689–692. [PubMed] [Google Scholar]
- WAGNER R. H., BRANNAN W. M., Jr, BRINKHOUS K. M. Antiaccelerator (anticonvertin) activity of canine plasma and serum. Proc Soc Exp Biol Med. 1955 Jun;89(2):266–270. doi: 10.3181/00379727-89-21779. [DOI] [PubMed] [Google Scholar]
